Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity

Histopathological and magnetic resonance imaging (MRI) studies have shown white matter (WM) damage in early stages of multiple sclerosis (MS) beyond the apparent T2-hyperintense lesions. These changes in normal appearing WM (NAWM) are important with regard to the clinical picture and prognosis. However, the detection of changes within NAWM has so far required special imaging techniques commonly not available in clinical routine and, hence, at large scale. The purpose of this study was to detect MS-related damage of NAWM by conventional MRI. As, within NAWM, the myelin content mainly drives the T1-weighted (T1w) signal, we scaled it by the T2w signal. We tested the hypothesis that the mean T1w/T2w ratio of NAWM is decreased in MS compared to healthy controls (HC) and that it correlates with clinical measures. We developed a pipeline to determine the individual mean values of this ratio within NAWM. We studied 244 patients in early disease stages of MS (mean age 37 ± 10 years, mean disease duration 3.1 ± 2.3, Expanded Disability Status Scale 1.3 ± 1), and 78 HC (mean age 31 ± 8 years). Compared to HC, the mean T1w/T2w ratio was lowered in the patient group (P < 0.001). The difference remained significant after restricting the analysis to patients with a disease duration of 5 years or less and without disease modifying drugs. Our measures also correlated with clinical scores. We believe that the mean T1w/T2w ratio is a promising candidate to assess MS-related tissue damage within NAWM at large scale.

[1]  Stephen M. Rao,et al.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure. , 1999, Brain : a journal of neurology.

[2]  G J Barker,et al.  Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities , 2003, Multiple sclerosis.

[3]  J. Thiran,et al.  Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis , 2014, Annals of Clinical and Translational Neurology.

[4]  S. Reingold,et al.  The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.

[5]  S. Rombouts,et al.  The contribution of MRI in assessing cognitive impairment in multiple sclerosis , 2010, Neurology.

[6]  Christine C. Boucard,et al.  White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI , 2013, Multiple sclerosis.

[7]  Hans Lassmann,et al.  The Immunopathology of Multiple Sclerosis: An Overview , 2007, Brain pathology.

[8]  A. Barkovich Concepts of myelin and myelination in neuroradiology. , 2000, AJNR. American journal of neuroradiology.

[9]  F. Barkhof The clinico‐radiological paradox in multiple sclerosis revisited , 2002, Current opinion in neurology.

[10]  Gilles Edan,et al.  Evidence for a two-stage disability progression in multiple sclerosis , 2010, Brain : a journal of neurology.

[11]  David H. Miller,et al.  Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes , 2010, Journal of magnetic resonance imaging : JMRI.

[12]  Elizabeth Fisher,et al.  Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations , 2011, Annals of neurology.

[13]  Barkovich Aj Concepts of Myelin and Myelination in Neuroradiology , 2000 .

[14]  Jeff F. Dunn,et al.  Iron in multiple sclerosis: roles in neurodegeneration and repair , 2014, Nature Reviews Neurology.

[15]  E. Radue,et al.  Association of cognitive impairment and lesion volumes in multiple sclerosis – A MRI study , 2014, Clinical Neurology and Neurosurgery.

[16]  M Filippi,et al.  Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.

[17]  F. Turkheimer,et al.  Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome. , 2015, Brain : a journal of neurology.

[18]  D. Auer,et al.  Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. , 2009, Brain : a journal of neurology.

[19]  G J Barker,et al.  Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. , 2005, Brain : a journal of neurology.

[20]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[21]  Bernhard Hemmer,et al.  An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis , 2012, NeuroImage.

[22]  M. Czisch,et al.  Brain Volume and Diffusion Markers as Predictors of Disability and Short-Term Disease Evolution in Multiple Sclerosis , 2012, American Journal of Neuroradiology.

[23]  L. Kappos,et al.  The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue , 2009, Multiple sclerosis.

[24]  A. Kassner,et al.  Normal-Appearing White Matter Permeability Distinguishes Poor Cognitive Performance in Processing Speed and Working Memory , 2013, American Journal of Neuroradiology.

[25]  David H. Miller,et al.  Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis. , 2015, Brain : a journal of neurology.

[26]  D. V. van Essen,et al.  Mapping Human Cortical Areas In Vivo Based on Myelin Content as Revealed by T1- and T2-Weighted MRI , 2011, The Journal of Neuroscience.

[27]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.